KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

OFTAN TIMOLOL 0.5 % EYE DROPS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

0.5 %

 

GENERIC NAME:

TIMOLOL

 

MANUFACTURER:

SANTEN OY

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Glaucoma, open- angle

Hypertension, ocular

 

SIDE EFFECTS:

breast abscess

change in taste

chest pain

confusion or mental depression

congestive heart failure

coughing, wheezing, or troubled breathing, especially in patients with predisposition to bronchoconstriction

cystitis

diarrhea

dizziness or feeling faint

drowsiness

ear pain

epistaxis

gout

hallucinations

headache

heartblock

hypercholesterolemia

hyperlipidemia

hypertension

hypertonia

hypotension

impotence

infection

insomnia

irregular, slow, or pounding heartbeat

nasal congestion

nausea or vomiting

otitis media

paresthesia

pharyngitis

psoriasis

rhinitis or sinusitis

systemic lupus erythematosus

tachycardia

tinnitus

toxic epidermal necrolysis

unusual tiredness or weakness

vascular anomoly

vertigo

Blurred vision, transient

decreased night vision

stinging of eye or other eye irritation, transient upon administration of medication

Browache

constipation

corneal sensitivity

crusting of eyelashes

dermatitis

dryness of eye

dyspepsia

foreign body sensation

increased sensitivity of eye to light

redness, itching, stinging, burning, or watering of eye or other eye irritation

tendinitis

Conjunctival hyperemia

Anisocoria

blepharitis

blepharoconjunctivitis

cataracts

conjunctivitis

corneal punctate keratitis

dermatitis of eyelid

edema

iridocyclitis

keratitis

blepharoptosis

corneal staining

decreased corneal sensitivity

diplopia

eye pain

glossitis

vision disturbances

vitreous disorders

Allergic reaction

alopecia

anxiety or nervousness

arthritis or myalgia

ataxia

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

>> Allergic reactions, severe

>> Bronchitis, nonallergenic

>> Emphysema

>> Pulmonary function impairment, other

Cerebrovascular insufficiency

>> Congestive heart failure

>> Cardiac failure

Heart block

>> Diabetes mellitus, especially labile diabetes

>> Hypoglycemia

>> Hyperthyroidism

Myasthenia gravis

 

ADULT DOSE:

Ophthalmic antiglaucoma agent-Topical, to the conjunctiva, 1 drop of a 0.25 or 0.5% solution of timolol (base) one or two times a day.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Ophthalmic antiglaucoma agent-Infants and children up to 10 years of age: Topical, to the conjunctiva, 1 drop of a 0.25% solution of timolol (base) one or two times a day. Children 10 years of age and older: See Usual adult and adolescent dose. Note: Nasolacrimal occlusion should be emphasized to patient. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT